ClinicalTrials.gg
Enrolling by invitationNCT07895407Updated Oct 26, 2026

Effects of Ciprofol on Perioperative Neurocognitive Function in Elderly Patients Undergoing Daytime Surgery

A Phase 4 interventional study of Ciprofol and propofol in PND and POCD - Postoperative Cognitive Dysfunction, sponsored by Second Affiliated Hospital of Wenzhou Medical University. Enrolling by invitation at 1 site in China. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-26.

Sponsored by Second Affiliated Hospital of Wenzhou Medical University · Phase 4, Interventional, and Screening

From the registry’s dates

  • Registered 1 year 5 months after the study started (first participant enrolled Apr 2025, registered Oct 2026).
Updated Oct 26, 2026Newly registeredGo to Updates ↓
Phase
Phase 4
Study type
Interventional
Enrollment
148
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

As life expectancy increases, the rate of disability among elderly individuals is also rising. Elderly patients undergoing home-based rehabilitation after surgery without medical supervision may experience complications and adverse events such as nausea, vomiting, or bleeding, which can impair recovery of daily living functions and commonly lead to readmission after discharge-particularly in older adults with multiple comorbidities, declining physical function, or cognitive impairment, who face a higher risk. Postoperative neurocognitive disorder (PND) is common following anesthesia and surgery, affecting up to 65% of adults aged 65 and older, and is associated with significant morbidity and mortality. Most patients do not undergo baseline or follow-up neuropsychological testing during the perioperative period or afterward, limiting the identification and early intervention for PND. With increasing life expectancy and a growing number of elderly patients undergoing surgery, the incidence of PND is expected to continue rising, primarily manifesting as declines in memory, attention, information processing, and cognitive flexibility. Current clinical studies suggest that advanced age, low educational level, pre-existing cognitive impairment, and alcohol and/or substance abuse are strong risk factors for developing PND. The perioperative period represents a critical window for identifying and assessing PND.

02

Conditions studied

  • PND
  • POCD - Postoperative Cognitive Dysfunction
03

In context

Postoperative Cognitive Complications

270 studies on the registry are indexed under Postoperative Cognitive Complications; 57 are open to participants now.

This study's planned enrollment of 148 is above the median of 110 across 151 interventional studies indexed under Postoperative Cognitive Complications.

Browse Postoperative Cognitive Complications studies →

Lead sponsor

Second Affiliated Hospital of Wenzhou Medical University is the lead sponsor of 137 studies on the registry; 46 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age ≥ 65 years
  2. ASA I-II grade or ASA III grade, with stable coexisting diseases for more than 3 months, and after strict assessment and preparation for optimization.

Exclusion criteria

Exclusion criteria:

  1. Acute central nervous system injury
  2. Diseases with drug contraindications or severe lesions in important organs such as the heart, brain, lungs, etc.
  3. Severe liver or kidney dysfunction
  4. History of schizophrenia, epilepsy, Parkinson's disease, myasthenia gravis or other mental disorders in the past
  5. History of alcoholism and/or drug abuse
  6. Total intraoperative hypotension time ≥ 10 minutes or hypoxemia occurred
  7. No responsible adult accompanying the patient 24 hours after discharge
  8. Patients with poor language expression ability or unwillingness to follow the protocol or perform the procedures in this study.
05

Study design

Phase
Phase 4
Primary purpose
Screening
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
148 participants (estimated)

Study arms

  • Experimental
    Effects of Ciprofol on Perioperative Neurocognitive Function in Elderly Patients Undergoing Daytime

    Continuous infusion of ciprofol during general anesthesia

    Drug: Ciprofol

  • Experimental
    Effects of Propofol on Perioperative Neurocognitive Function in Elderly Patients Undergoing Daytime

    Drug: propofol

Interventions

  • Continuous infusion of ciprofol during general anesthesia

  • Continuous infusion of propofol during general anesthesia

06

What researchers measure

Primary outcomes

  1. The incidence rate of PND

    The primary outcome was the incidence of PND within 24 hours after surgery.

    Time frame: At least 1 day before the operation, 4 hours after the operation, and 24 hours after the operation.

Secondary outcomes

  1. The DST score

    The changes in DST scores before and after the surgery

    Time frame: At least 1 day before the operation, 4 hours after the operation, and 24 hours after the operation.

  2. The MMSE score

    The changes in MMSE scores before and after the surgery

    Time frame: At least 1 day before the operation, 4 hours after the operation, and 24 hours after the operation.

  3. anesthetic dosage

    Time frame: during operation

  4. The TMT-A/B score

    Time frame: At least 1 day before the operation, 4 hours after the operation, and 24 hours after the operation.

  5. The BNT score

    Time frame: At least 1 day before the operation, 4 hours after the operation, and 24 hours after the operation.

  6. The AVLT-H score

    Time frame: At least 1 day before the operation, 4 hours after the operation, and 24 hours after the operation.

  7. the clock drawing test score

    Time frame: At least 1 day before the operation, 4 hours after the operation, and 24 hours after the operation.

  8. The QoR-15 score

    Time frame: At least 1 day before the operation, 4 hours after the operation, and 24 hours after the operation.

07

Study locations

1 site
  • Second Affiliated Hospital of Wenzhou Medical University
    Wenzhou, Zhejiang, China
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Apr 2025 (actual). Primary completion is estimated for Mar 2027, 22 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 5, 2026
First posted
Oct 26, 2026
StartActual
Apr 25, 2025
Primary completionEst.
Mar 1, 2027
CompletionEst.
Jun 30, 2027
Last update
Oct 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 26, 2026
Show all 1 update
  1. Oct 26, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07895407
Collaborators
Affiliated Wenling Hospital of Wenzhou Medical University
Responsible party
Ting Li (Principal Investigator, Second Affiliated Hospital of Wenzhou Medical University) — Principal investigator
First posted
Oct 26, 2026
Start date
Apr 25, 2025
Primary completion
Mar 1, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Oct 26, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Ciprofol · Propofol

Start the discussion